Ignite Creation Date:
2025-12-25 @ 2:58 AM
Ignite Modification Date:
2025-12-30 @ 4:33 PM
Study NCT ID:
NCT07037433
Status:
RECRUITING
Last Update Posted:
2025-11-13
First Post:
2025-06-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
Sponsor:
Amgen
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-07-25
Start Date Type:
ACTUAL
Primary Completion Date:
2028-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-09-29
Completion Date Type:
ESTIMATED
First Submit Date:
2025-06-16
First Submit QC Date:
None
Study First Post Date:
2025-06-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-11-12
Last Update Post Date:
2025-11-13
Last Update Post Date Type:
ESTIMATED